Retatrutide is a newly developed therapy that acts as a strong GLP-1 receptor agonist. This revolutionary approach holds significant hope for managing type 2 diabetes. By imitating the actions of natural GLP-1, Retatrutide improves insulin secretion and reduces glucagon release, leading to improved glucose control. Clinical trials have demonstrated